By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Solace Therapeutics, Inc. 

139 Newbury Street

Framingham  Massachusetts  01701  U.S.A.
Phone: 508-283-1200 Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
Solace Therapeutics, Inc. Release: Two Clinical Abstracts On The Vesair Bladder Control System For Treating Stress Urinary Incontinence (SUI) To Be Presented At The American Urogynecology Society(AUGS) Meeting In Denver, CO 9/28/2016 11:51:24 AM
Solace Therapeutics, Inc. Release: Two Clinical Abstracts On The VesairĀ® Bladder Control System For Treating Stress Urinary Incontinence (SUI) To Be Presented At The American Urogynecologic Society Meeting In Denver, CO 9/28/2016 8:09:27 AM
Solace Therapeutics, Inc. Release: Six-Month Data From The SOLECT Trial Awarded One Of The "Best" Poster Presentations At The Upcoming 31st European Association Of Urology (EAU) Congress In Munich, Germany 3/10/2016 10:39:03 AM
Solace Therapeutics, Inc. Release: Abstract Presentations Address Key Clinical Questions Regarding The Vesair Bladder Control System For The Treatment For Stress Urinary Incontinence (SUI) 10/6/2015 10:44:05 AM
Solace Therapeutics, Inc. Release: Abstract Presentations Address Key Clinical Questions Regarding The Vesair Bladder Control System For The Treatment For Stress Urinary Incontinence (SUI) 10/6/2015 10:35:27 AM
Solace Therapeutics, Inc. Completes Enrollment Of The SUCCESS Clinical Trial For The Vesair Bladder Control System For Stress Urinary Incontinence 8/26/2015 10:51:20 AM
Solace Therapeutics, Inc. Release: Presentations At The International Urogynecology Association (IUGA) Conference In Nice, France Continue To Demonstrate Safety And Efficacy Of The VesairĀ® Bladder Control Procedure As A Treatment For Stress Urinary Incontinence(SUI) 6/8/2015 10:51:25 AM
Solace Therapeutics, Inc. Release: A Second Randomized Controlled Trial (RCT) Of The Vesair Bladder Control System Meets Study Endpoints With Statistical Significance 2/17/2015 2:20:53 PM
Solace Therapeutics, Inc. Wins Two FDA Clearances Towards Providing Women An Office-Based Treatment For Stress Urinary Incontinence (SUI). 6/18/2014 10:25:16 AM
Solace Therapeutics, Inc. Adds New Member to Board of Directors 9/17/2013 8:37:19 AM
12
//-->